Evidence map›Paper›PMID 35453158›Full record

ArticleFortschritte der Neurologie-Psychiatrie2022

[Treatment of Sialorrhea with Botulinum Neurotoxin Type A - Consensus Practice Recommendations for Children and Adults].

Wolfgang H Jost, Tobias Bäumer, Andrea Bevot, Ulrich Birkmann, Carsten Buhmann, Maria Grosheva, Orlando Guntinas-Lichius, Ute Mlynczak, Sebastian Paus, Christina Pflug and 4 more

Erratum issuedOpen access · hybridAbstract readConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Fortschritte der Neurologie-Psychiatrie, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 12 institutions in 1 country.

Wolfgang H JostParkinson-Klinik Ortenau, Wolfach, Germany.ORCID 0000-0002-8574-3297
Tobias BäumerInstitut für Systemische Motorikforschung, CBBM; Sektion Zentrum für Seltene Erkrankungen, Universität zu Lübeck/Universitätsklinikum Schleswig-Holstein, Lübeck, Germany.
Andrea BevotNeuropädiatrie, Entwicklungsneurologie, Sozialpädiatrie, Universitätsklinik für Kinder und Jugendmedizin, Tübingen, Germany.
Ulrich BirkmannSchluckambulanz, GFO Kliniken Troisdorf, Troisdorf, Germany.
Carsten BuhmannNeurologie, Universitatsklinikum Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0001-8540-3789
Maria GroshevaHNO-Uniklinik Köln, Universität zu Köln, Medizinische Fakultät, Köln, Deutschland Department of Otorhinolaryngology, Head and Neck Surgery, University of Cologne, Medical Faculty, Cologne, Germany.
Orlando Guntinas-LichiusKlinik für Hals-, Nasen- Ohrenheilkunde, Universitätsklinikum Jena, Jena, Germany.
Ute MlynczakUniReha GmbH, Klinik und Poliklinik für HNO-Heilkunde, Kopf- und Halschirurgie, Uniklinik Köln, Köln, Germany.
Sebastian PausFachabteilung Neurologie, GFO Kliniken Troisdorf, Troisdorf, Germany.
Christina PflugKlinik und Poliklinik für Hör-, Stimm- und Sprachheilkunde, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Sebastian SchröderPädiatrische Neurologie, Entwicklungsneurologie, iSPZ, Dr. von Haunersches Kinderspital, Klinikum der Universität München, München, Germany.
Armin SteffenKlinik für HNO-Heilkunde, Universität zu Lübeck/UKSH Campus Lübeck, Lübeck, Germany.
Bernd WilkenNeuropädiatrie mit Sozialpädiatrischem Zentrum, Klinikum Kassel, Kassel, Germany.
Steffen BerweckFachzentrum für Pädiatrische Neurologie, Neurorehabilitation und Epileptologie, Schön Klinik, Vogtareuth, Vogtareuth, Germany.
Atos Medical · DEUniversität Hamburg · DEKlinikum Kassel · DEKlinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde · DEKlinik und Poliklinik für Hals-Nasen-Ohren-Heilkunde · DEKlinik und Poliklinik für Kinder- und Jugendmedizin · DEMünchen Klinik · DEParkinson-Klinik Ortenau · DESchön Klinik Vogtareuth · DEUniversity Hospital Schleswig-Holstein · DEUniversity of Cologne · DEUniversity of Lübeck · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sialorrhea, uncontrolled, excessive drooling, accompanies different, mostly neurological disorders from childhood to adulthood. With incobotulinumtoxinA (Xeomin, IncoBoNT/A, Merz Pharmaceuticals GmbH), an approved medication for the treatment of sialorrhea has been available since 2019. Patient selection, possible therapy goals, treatment and the management of specific treatment situations build the focus of this interdisciplinary expert consensus recommendations with the intent to facilitate access to treatment and to contribute to qualified botulinum toxin therapy.

Indexed as

Botulinum Toxins, Type ANervous System DiseasesSialorrheaAdolescentAdultChildHumansTreatment OutcomeYoung AdultBotulinum Toxins, Type A

Identifiers

PMID35453158
PMCPMC9113851
OpenAlexW4224301966

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.